Impact on Vulnerable Populations After Discontinuation of Continuous Glucose Monitoring in Patients With Type 2 Diabetes

ANNALS OF PHARMACOTHERAPY · Published 2026-07-28 · DOI 10.1177/10600280261470410

Free full text

Authors (6)

Bernadette Asias-Dinh, Natalie Rosario, Kevin Garey, Aya Hussein, Minoo Madi, Jodie Gee

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Asias-Dinh, B., Rosario, N., Garey, K., et al. (2026). Impact on Vulnerable Populations After Discontinuation of Continuous Glucose Monitoring in Patients With Type 2 Diabetes. ANNALS OF PHARMACOTHERAPY. https://doi.org/10.1177/10600280261470410

Related articles

• Effectiveness of Continuous Glucose Monitoring in a Pharmacist-Run Collaborative Drug Therapy Management Service for Underserved Individuals With Diabetes: A Quasi-Experimental Study · Clinical Diabetes · 2025 · Cites or is cited by this article
• Insulin Glargine Use in Dexamethasone-Induced Hyperglycemia: A Retrospective Cohort Analysis · ANNALS OF PHARMACOTHERAPY · 2026 · Same journal
• The Need for Better Stewardship of Medication Use in Older Adults · ANNALS OF PHARMACOTHERAPY · 2026 · Same journal
• Description of Treatment Strategies and Patient Outcomes for Hospitalized Patients With Lyme Carditis · ANNALS OF PHARMACOTHERAPY · 2026 · Same journal
• Four-Year Evaluation of a Pharmacists-Providers Collaborative Iron Deficiency Clinic in Heart Failure Care · ANNALS OF PHARMACOTHERAPY · 2026 · Same journal
• Comment on “Safety and Efficacy of the Prescribing Practices of Ketamine for Pain and Agitation in the Medical Intensive Care Unit” · ANNALS OF PHARMACOTHERAPY · 2026 · Same journal
• Prognostic Value of Mean Platelet Volume-To-Monocyte Ratio and Ferritin in NSTEMI: Independent Impact of Angiotensin-Converting Enzyme Inhibitor Therapy · ANNALS OF PHARMACOTHERAPY · 2026 · Same journal
• ApoC[III] You Later: A Review of Plozasiran for the Management of Familial Chylomicronemia Syndrome · ANNALS OF PHARMACOTHERAPY · 2026 · Same journal
• Process Improvement Is Not Yet Long-Term Effectiveness: Interpreting a Pharmacist-Provider Iron Deficiency Clinic · ANNALS OF PHARMACOTHERAPY · 2026 · Same journal
• Severe Phototoxic Skin Reaction Associated With Vandetanib: Implications for Pharmaceutical Care · ANNALS OF PHARMACOTHERAPY · 2026 · Same journal